Status:
ACTIVE_NOT_RECRUITING
Duke COVID-19 Shared Data and Specimen Repository
Lead Sponsor:
Duke University
Conditions:
COVID-19
Eligibility:
All Genders
Brief Summary
The purpose of this data repository is to provide a secure and centralized storage location and resource for the collection of essential data and medical specimens, across COVID-19 related protocols a...
Detailed Description
The aim of this data repository is to provide a secure and centralized storage location and resource for the collection of core variables of interest, as well as the retaining of relevant patient samp...
Eligibility Criteria
Inclusion
- Subjects will be included in this data repository if they meet the enrollment criteria of any linked/participating IRB-approved protocol, or if they are not enrolled in another COVID-related study but meet one of the following inclusion criteria:
- Suspected novel Coronavirus (nCoV) infection (Person Under Investigation) and/or
- Laboratory proven acute novel Coronavirus (nCoV) infection and/or
- Primary admitting diagnosis of nCoV infection
- Studies will include:
- Any COVID-19 clinical research studies recruiting Duke patients
- Excludes: protocols sharing non-consented EHR data with national/international repositories and studies that are recruiting community participants
Exclusion
Key Trial Info
Start Date :
April 18 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 30 2028
Estimated Enrollment :
100000 Patients enrolled
Trial Details
Trial ID
NCT04368234
Start Date
April 18 2020
End Date
April 30 2028
Last Update
July 24 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Duke University Medical Center
Durham, North Carolina, United States, 27710